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http://dx.doi.org/10.1016/j.ccr.2012.10.025SUMMARYTumors are largely classified by histologic appearance, yet morphologic features do not necessarily predict
cellular origin. To determine the origin of pancreatic ductal adenocarcinoma (PDA), we labeled and traced
pancreatic cell populations after induction of a PDA-initiating Kras mutation. Our studies reveal that ductal
and stem-like centroacinar cells are surprisingly refractory to oncogenic transformation, whereas acinar
cells readily form PDA precursor lesions with ductal features. We show that formation of acinar-derived
premalignant lesions depends on ectopic induction of the ductal gene Sox9. Moreover, when concomitantly
expressed with oncogenic Kras, Sox9 accelerates formation of premalignant lesions. These results provide
insight into the cellular origin of PDA and suggest that its precursors arise via induction of a duct-like state in
acinar cells.INTRODUCTION
Defining tumor-initiating events is critically important for devel-
oping early cancer detection methods and effective treatments.
In the past, the cell type responsible for tumor initiation has often
been inferred based on the histologic appearance of the tumor.
However, morphologic features do not necessarily predict
a lineage relationship (Goldstein et al., 2010), which can only
be determined by lineage tracing studies.
Invasive pancreatic ductal adenocarcinoma (PDA) is believed
to arise from a spectrum of preneoplastic mucinous lesions with
ductal morphology, namely pancreatic intraepithelial neoplasias
(PanINs), the most common precursor lesions observed in
humans, as well as mucinous cystic neoplasias (MCNs) andSignificance
PDA has a dismal prognosis, largely because it is mostly diag
methods and treatments, it is essential to understand the prim
populations in the presence and absence of tissue injury in mi
PDA precursor lesions from adult pancreatic acinar cells, but
and gain-of-function approaches we identify the ductal fate det
lignant acinar cell reprogramming. Our findings demonstrate a
a potential target for preventing early tumor-initiating events.
Canintraductal papillary mucinous neoplasias (IPMNs) (Hezel et al.,
2006). During disease progression, accumulation of genetic
mutations in these lesions leads to an increasing degree of atypia
and ultimately PDA (Feldmann et al., 2007). The earliest detect-
able mutations found in preneoplastic lesions are activating
mutations of theKRASgene (Kanda et al., 2012). The significance
of Krasmutations for disease initiation has been demonstrated in
mice, where expression of the constitutively active KrasG12D
allele induces PanINs and after a significant latency period also
PDA (Hingorani et al., 2003). In KrasG12D-expressing mice, PanIN
formation coincides with, or is preceded by, acinar-to-ductal
metaplasia (ADM), characterized by replacement of acinar cells
with cells expressing ductal markers, such as CK19 and the
ductal fate determinant Sox9 (Morris et al., 2010; Zhu et al.,nosed at an advanced stage. For developing early detection
ary events leading to tumor initiation. By tracing specific cell
ce, we demonstrate that oncogenic Kras can readily induce
not from ductal or centroacinar cells. Moreover, using loss-
erminant Sox9 as a critical mediator of Kras-induced prema-
key role for acinar cells in PDA initiation and reveal Sox9 as
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Figure 1. SOX9 Is Expressed in Human
Premalignant and Malignant Pancreatic
Lesions
(A–H) Immunohistochemistry for SOX9 and
hematoxylin counterstain on a tissue microarray
spotted with human pancreatic tissue cores.
Representative images showing SOX9 expression
in normal pancreatic ducts (A), chronic pancrea-
titis (B), MCN (C), IPMN (D), pancreatic intra-
epithelial neoplasia 1 (PanIN1) (E), PanIN2 (F),
PanIN3 (G), and PDA (H).
(I) Number of tissue cores within each phenotypic
category displaying no, weak, or strong SOX9
staining intensity. Scale bars: 100 mm.
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Sox9-Dependent Initiation of Pancreatic Cancer2007). ADM is also observed in pancreatitis, which is a significant
risk factor for PDA in humans (Lowenfels et al., 1993) and accel-
erates KrasG12D-mediated PanIN and PDA formation in mice
(Carrie`re et al., 2009; Guerra et al., 2007; Morris et al., 2010).
These findings imply that oncogenic Kras mutations induce
ADM, PanINs and ultimately PDA. However, it is still unclear
whether ADM and PanINs primarily arise by expansion of ductal
cells and secondary replacement of acinar cells or by direct re-
programming of acinar cells into cells with ductal morphology.
Because previous studies have modeled PDA initiation mostly
by expressing oncogenic Kras in all cell types of the pancreas
(Aguirre et al., 2003; Hingorani et al., 2003, 2005), little is known
about its cell of origin. In mice deficient for the tumor suppressor
Pten, the formation of invasive pancreatic cancer is associated
with increased proliferation of centroacinar cells (CACs) (Stanger
et al., 2005), which reside at the tips of the ductal tree. CACs
express some markers of embryonic pancreatic progenitors
and exhibit features of tissue stem cells in vitro (Miyamoto
et al., 2003; Rovira et al., 2010). Since numerous tumors have
been shown to originate from tissue stem cells (Visvader,
2011), it has been proposed that CACs are the cell of origin for
PanINs and PDA (Miyamoto et al., 2003; Stanger et al., 2005).
However, this contention has not been directly tested, largely
because genetic tools to target ductal and CACs have only
recently been generated (Kopp et al., 2011; Solar et al., 2009).
Genetic studies, using CK19 promoter-based alleles to activate
oncogenic Kras in ductal cells, suggest that PanINs rarely arise
from ducts (Brembeck et al., 2003; Ray et al., 2011). Yet, the
rather exclusive targeting of larger ducts in these studies pre-738 Cancer Cell 22, 737–750, December 11, 2012 ª2012 Elsevier Inc.cluded assessing susceptibility of CACs
to KrasG12D-mediated PanIN induction.
Previous studies have shown that
oncogenic Kras can convert acinar
cells into duct-like cells and PanINs (Car-
rie`re et al., 2007; De La O et al., 2008;
Guerra et al., 2007; Habbe et al., 2008;
Morris et al., 2010). While these studies
suggest acinar-to-ductal reprogramming
(ADR) as a possible mechanism for initi-
ating PanINs, it is unclear whether PanINs
are more readily induced after direct
oncogenic transformation of ductal or
CACs. Moreover, it is unknown whether
inducers of ductal cell identity, such asSox9 (Delous et al., 2012; Shih et al., 2012), play a role in the
induction of PanINs from acinar cells.
In this study, we directly compared the propensity of ductal/
CACs and acinar cells to form PanINs and investigated the
molecular mechanisms that underlie PanIN formation.
RESULTS
SOX9 Is Expressed in Human Premalignant and
Malignant Pancreatic Lesions
Under normal conditions, the transcription factor Sox9 is ex-
pressed in ductal and CACs, but not acinar cells (Seymour
et al., 2007). In addition, Sox9 is induced during ADM and ex-
pressed in PanINs and PDA (Morris et al., 2010; Prevot et al.,
2012). To comprehensively examine SOX9 expression in the
human pancreas, we used a tissue microarray for immunohisto-
chemical analysis of SOX9 expression in different pancreatic
lesions (Figures 1A–1H). SOX9was expressed in chronic pancre-
atitis, as well as premalignant and malignant lesions, including
MCNs, IPMNs, PanINs, and PDA. Low-grade PanINs were
uniformly SOX9+, whereas higher-grade PanIN2/3 lesions and
PDA displayed heterogeneous SOX9 expression (Figure 1L;
72% of PanIN2/3 and 69% of PDA were SOX9+). These findings
suggest that a SOX9+ state is associated with PDA initiation.
KrasG12D-Induced PanINs Predominantly Arise from
Acinar but Not Ductal/Centroacinar Cells
To determine whether PanINs arise from Sox9-expressing
ductal/CACs or from acinar-derived duct-like cells ectopically
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Figure 2. KrasG12D Expression in Acinar, but
not in Ductal/Centroacinar Cells, readily
Induces PanIN Formation
(A) Sox9CreER;R26RYFP and Ptf1aCreER;R26RYFP
mice were injected once with tamoxifen (TM) at
postnatal day (p) 10 and analyzed at p14 or at 8 to
17 months (mo) of age.
(B–H) Quantification of Sox9+ or Cpa1+ cells ex-
pressing YFP at p14 (n = 4; B). H&E (C, E, and G) or
Alcian blue and eosin (D, F, and H) staining of
pancreatic sections from 8- to 17-month-old
control (C and D), Ptf1aCreER;LSL-KrasG12D;
R26RYFP (E and F), or Sox9CreER;LSL-KrasG12D;
R26RYFP (G and H) mice reveals abundant Alcian
blue+ PanINs only in Ptf1aCreER;LSL-KrasG12D;
R26RYFP mice.
(I–L) Immunohistochemistry of YFP in 8- to 17-
month-old mice shows expression of YFP in
acinar cells in Ptf1aCreER;R26RYFP mice (I), arrows)
and ductal/CACs in Sox9CreER;R26RYFPmice (K),
arrowheads). PanINs in Ptf1aCreER;LSL-KrasG12D;
R26RYFP (J) and Sox9CreER;LSL-KrasG12D;
R26RYFP (L) mice are YFP+, indicating an acinar or
ductal/CAC origin, respectively.
(M) Quantification of Alcian blue+ pancreatic area
in 8- to 17-month-old mice (n = 9 in Ptf1aCreER;
LSL-KrasG12D mice; n = 6 in Sox9CreER;
LSL-KrasG12D mice). The Alcian blue+ area in
Sox9CreER;LSL-KrasG12D;R26RYFP mice was
multiplied by 4.6 (normalized) to account for the
greater total number of recombined cells in
Ptf1aCreER;R26RYFP mice (see Figure S1L).
(N) Schematic showing the predominantly acinar
origin of PanINs after expression of oncogenic
Kras. Values are shown as mean ± SEM. **p <
0.01. Scale bars: 1 mm (C–H) and 100 mm (I–L).
See also Figure S1.
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Sox9-Dependent Initiation of Pancreatic Cancerexpressing Sox9, we directly compared the propensity of ductal/
CACs and acinar cells to form PanINs in response to oncogenic
Kras. To inducibly recombine the LSL-KrasG12D allele (hereafter
referred to as the KrasG12D allele) in ductal/CAC or acinar cells,
we used Sox9CreER or Ptf1aCreER mice, respectively. The Cre-
dependent R26RYFP reporter allele was included to assess
recombination efficiency and map the fate of Kras-active cells.
Four days after induction of recombination by tamoxifen at post-
natal day 10 (p10), we analyzed pancreatic labeling specificity
and efficiency by quantifying the percentage of ductal and acinar
cells expressing YFP (Figure 2A; Figure S1A available online). As
previously reported (Kopp et al., 2011), the Sox9CreER trans-
gene labeled cells throughout the entire ductal tree, including
CACs (Figures S1B and S1C; data not shown). On average, we
labeled 12% of all Sox9+ cells with the Sox9CreER transgene
and 10% of Cpa1+ acinar cells with the Ptf1aCreER allele (Figures
2B, S1D, and S1E). Quantification of nonlineage-specific recom-Cancer Cell 22, 737–750, Dbination events revealed R26RYFP recom-
bination in 0.02% of acinar cells by
Sox9CreER and 0.23% of Sox9+ cells by
Ptf1aCreER (Figure 2B). A similar pattern
of YFP expression was observed after
8 months or longer (Figures 2I and 2K),
confirming that acinar and ductal cellsdo not spontaneously convert into other pancreatic cell types
(Desai et al., 2007; Kopp et al., 2011; Solar et al., 2009; Strobel
et al., 2007). Overall, this analysis shows that the Sox9CreER
transgene and Ptf1aCreER allele specifically target the ductal/
CAC and acinar cell compartments, respectively. Moreover, the
KrasG12D allele was effectively recombined by both Ptf1aCreER
and Sox9CreER (Figure S1F).
To assess the frequency of PanINs arising from acinar or
ductal/CACs after Kras activation, we examined pancreata
from Ptf1aCreER;KrasG12D;R26RYFP and Sox9CreER;KrasG12D;
R26RYFP mice 8 to 17 months after KrasG12D induction (Fig-
ure 2A). Corroborating previous studies, showing that Kras
activation in acinar cells can induce PanINs (Carrie`re et al.,
2007; De La O et al., 2008; Gidekel Friedlander et al., 2009;
Guerra et al., 2007; Habbe et al., 2008), all Ptf1aCreER;
KrasG12D;R26RYFP mice displayed abundant lesions with histo-
logic and molecular characteristics of PanINs, including highecember 11, 2012 ª2012 Elsevier Inc. 739
Table 1. Quantification of PanIN Frequency in Ptf1aCreER;LSL-KrasG12D;R26RYFP and Sox9CreER;LSL-KrasG12D;R26RYFP Mice
Genotype n
Tamoxifen Injection
Age (days)
Analysis Age
(months) Additional Treatment
Number of Mice with PanINs
(% of Total Mice)
Ptf1aCreER; 12 10 8–17 None 12 (100)
LSL-KrasG12D;R26RYFP
Sox9CreER; 14 10 8–16 None 8 (57)
LSL- KrasG12D;R26RYFP
Ptf1aCreER; 4 10 2 Caerulein 4 (100)
LSL-KrasG12D;R26RYFP
Ptf1aCreER; 4 10 2 Saline 4 (100)
LSL-KrasG12D;R26RYFP
Sox9CreER; 5 10 2 Caerulein 3 (40)
LSL-KrasG12D;R26RYFP
Sox9CreER; 9 10 2 Saline 1 (11)
LSL-KrasG12D;R26RYFP
See also Table S1.
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Sox9-Dependent Initiation of Pancreatic Canceracidic mucin content, indicated by Alcian blue staining, and
expression of Muc5AC and Claudin18 (Figures 2C–2F, S1G,
and S1H; Table 1). Expression of YFP further confirmed that
the PanINs originated from acinar cells (Figure 2J).
In contrast to Ptf1aCreER;KrasG12D;R26RYFP mice, pancreatic
histology was largely normal in Sox9CreER;KrasG12D;R26RYFP
mice and PanINs were rarely observed (Figures 2C and 2G). Of
14 mice, no PanINs were detected in six mice and the remaining
mice had no more than ten PanINs per mouse (Tables 1 and S1).
As seen in PanINs originating from acinar cells (Figures 2F, S1G,
and S1H), the duct-derived lesions were Alcian blue+ (Figure 2H,
inset), and expressed Muc5AC and Claudin18 (Figures S1I and
S1J) and the lineage marker YFP (Figure 2L). However, unlike
acinar-derived PanINs, the duct-derived lesions were not
randomly distributed throughout the pancreas, but were more
often associated with large ducts (Figure S1J, arrow).
To thoroughly compare the extent of PanIN formation
from acinar and ductal/CACs, we quantified the Alcian blue+
area in Ptf1aCreER;KrasG12D;R26RYFP and Sox9CreER;KrasG12D;
R26RYFP mice on sections spaced every 140 mm throughout
the entire pancreas (Figure 2M). Notably, Alcian blue staining
can be present in duct-like lesions devoid of neoplastic features
and conversely, can be absent from high-grade PanIN lesions
(Cornish and Hruban, 2011; Strobel et al., 2007). Since the
majority of Alcian blue+ lesions in Ptf1aCreER;KrasG12D;R26RYFP
and Sox9CreER;KrasG12D;R26RYFP mice exhibited neoplastic
characteristics of PanINs and Alcian blue PanINs were rarely
observed (Figure S1K and data not shown), Alcian blue staining
appeared to be an accurate measure of PanIN frequency in
these models. In Ptf1aCreER;KrasG12D;R26RYFP mice, on average
6.7 ± 1.5% of the pancreas was Alcian blue+. In contrast, only
0.013 ± 0.004% of the pancreas exhibited Alcian blue staining
in Sox9CreER;KrasG12D;R26RYFP mice (Figure 2M). While this
result suggests a striking difference in the propensity of acinar
and ductal/CACs to give rise to PanINs, this quantification likely
overestimates the difference, because acinar cells are more
abundant than ductal cells and therefore a larger overall number
of cells will express KrasG12D in Ptf1aCreER;KrasG12D;R26RYFP
than in Sox9CreER;KrasG12D;R26RYFP mice. To account for this740 Cancer Cell 22, 737–750, December 11, 2012 ª2012 Elsevier Incdifference, we quantified the total number of recombined YFP+
cells in Sox9CreER;R26RYFP and Ptf1aCreER;R26RYFP mice
4 days after tamoxifen injection. After accounting for the 4.6-
fold difference (Figure S1L), Ptf1aCreER-induced Kras activation
still resulted in a 112-fold higher frequency of PanINs than
Sox9CreER-mediated Kras activation (Figure 2M). These data
show that acinar cells have a much greater propensity than
ductal/CACs to form PanINs in response to oncogenic Kras
(Figure 2N).
Acute Pancreatitis Promotes KrasG12D-Mediated PanIN
Formation from Acinar, but Not Ductal Cells
Previous studies have shown that caerulein-induced acute or
chronic pancreatitis accelerates KrasG12D-mediated PanIN and
PDA formation (Carrie`re et al., 2009; Gidekel Friedlander et al.,
2009; Guerra et al., 2007; Morris et al., 2010). In the absence
of oncogenic Kras, acute pancreatitis induces transient ADM fol-
lowed by reversion to normal acinar cell morphology (Jensen
et al., 2005; Morris et al., 2010). By contrast, acute pancreatitis
in the presence of oncogenic Kras leads to persistent ADR and
accelerated PanIN formation (De La O and Murtaugh, 2009;
Morris et al., 2010). To compare how pancreatitis affects PanIN
formation after ductal or acinar cell-specific Kras activation, we
induced caerulein-mediated acute pancreatitis in 6-week-old
Ptf1aCreER;KrasG12D;R26RYFP, Sox9CreER;KrasG12D;R26RYFP
and control mice and analyzed pancreatic tissue 2 or 21 days
later (Figures 3A and S2A). As reported (Morris et al., 2010), 2-
day post-caerulein treatment control mice exhibited widespread
ADM with characteristic degranulation of acinar cells and
appearance of cuboidal to columnar duct-like structures with
enlarged lumens (Figures 3B and 3C), which were replaced by
normal acini within 21 days (Figures 3D and 3E). In Ptf1aCreER;
KrasG12D;R26RYFP mice treated with saline, pancreas mor-
phology was largely normal, although small areas of ADM and
occasional PanINs were already evident by 9 weeks of age (Fig-
ure 3F, inset). Similar to control mice, caerulein induced wide-
spread ADM within 2 days (Figures 3F and 3G). However, these
changes were not transient and duct-like structures were re-
placed by PanINs after 21 days (Figures 3H and 3I). These.
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Figure 3. Acute Pancreatitis Promotes PanIN Formation from KrasG12D-Expressing Acinar Cells, but not Ductal/Centroacinar Cells
(A) Ptf1aCreER;LSL-KrasG12D;R26RYFP, Sox9CreER;LSL-KrasG12D;R26RYFP and control mice were injected once with tamoxifen (TM) at postnatal day (p) 10. At
6 weeks (w) of age, mice were treated with two sets of caerulein (CA) or saline injections on alternating days and analyzed 48 hr (h) or 21 days (d) later.
(B–D, F–H, and J–L) H&E staining reveals occasional PanINs in 9-week-old Ptf1aCreER;LSL-KrasG12D;R26RYFPmice (F, inset) and persistent ADM and PanINs 21d
after CA (H), but normal pancreas morphology in Sox9CreER;LSL-KrasG12D;R26RYFP and control mice (D and L). Asterisks denote PanINs.
(E, I, and M) Alcian blue and eosin staining of pancreatic sections from mice 21 days after CA treatment.
(N) Quantification of Alcian blue+ pancreatic area reveals a significant increase in PanINs after CA in Ptf1aCreER;LSL-KrasG12D;R26RYFP (n = 4), but not in
Sox9CreER;LSL-KrasG12D;R26RYFP mice (n = 5).
(O) Schematic showing that pancreatic injury promotes PanIN formation from KrasG12D-expressing acinar, but not ductal/centroacinar cells. N.S., not significant.
Values are shown as mean ± SEM. **p < 0.01. Scale bars: 100 mm.
See also Figure S2.
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Figure 4. Sox9 Is Necessary for and Accelerates KrasG12D-Induced PanIN Formation
(A and B) Immunohistochemistry shows Sox9 expression in ductal/centroacinar (CAC) (A, arrowheads), but not acinar cells in control mice. In 2-month-old
Ptf1aCre;LSL-KrasG12D mice, Sox9 is also detected in some acinar cells (B, arrows).
(C andD) Co-immunofluorescence staining for Sox9, CK19 andCpa1 confirms Sox9 expression in ductal/CACs (C’, arrowhead points to CAC) in controlmice and
shows Sox9+Cpa1+CK19- acinar cells in Ptf1aCre;LSL-KrasG12D mice (D’, arrowheads).
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Sox9-Dependent Initiation of Pancreatic Cancerobservations are consistent with previous findings (Morris et al.,
2010) and confirm that acute pancreatitis promotes PanIN
formation from KrasG12D-expressing acinar cells. In contrast to
Ptf1aCreER;KrasG12D;R26RYFP mice, virtually no PanINs were
observed 21 days after caerulein treatment of Sox9CreER;
KrasG12D;R26RYFP mice (Figures 3J–3M; Tables 1 and S1) and
pancreasmorphology was similar to control mice not expressing
oncogenic Kras (Figures 3D and 3E). These results suggest that
KrasG12D-expressing ductal cells have a low propensity to form
PanINs even when exposed to pro-neoplastic insults, such as
acute pancreatitis.
To directly compare how pancreatitis affects PanIN forma-
tion from KrasG12D-expressing acinar and ductal/CACs, we
quantified the Alcian blue+ area, which was predominately
composed of PanIN lesions (data not shown and Figure
S2B), in Sox9CreER;KrasG12D;R26RYFP and Ptf1aCreER;KrasG12D;
R26RYFP mice 21 days after caerulein treatment (Figure 3N). In
mice expressing KrasG12D in acinar cells, caerulein induced
a significant 20.9-fold increase in Alcian blue+ area. By contrast,
no significant increase was observed in Sox9CreER;KrasG12D;
R26RYFP mice. Examination of individual mice revealed an
increase in the overall number of mice exhibiting Alcian
blue+ PanINs in caerulein-treated compared to saline-treated
Sox9CreER;KrasG12D;R26RYFP mice (Table 1; three of five mice
had PanINs after caerulein treatment versus one of nine mice
after saline treatment). However, in mice with PanINs a total of
only one to two PanINs were found per pancreas (Table S1).
Overall, the Alcian blue+ area in caerulein-treated Sox9CreER;
KrasG12D;R26RYFP mice was similar to controls not expressing
the Kras oncogene (Figure 3N). Together, these data demon-
strate that acute pancreatitis potentiates PanIN formation
from KrasG12D-expressing acinar cells, but not from KrasG12D-
expressing ductal/CACs (Figure 3O).
Sox9 Is Necessary for KrasG12D-Mediated PanIN
Induction
Given that ADM and early PanINs are Sox9+ (Figure 1; Morris
et al., 2010; Prevot et al., 2012), but Sox9+ ductal cells are not
the predominant source of PanINs, we examined whether
Sox9 is induced in KrasG12D-expressing acinar cells prior to
ADM. In control mice, Sox9 expression was restricted to ductal
and CACs (Figures 4A and 4C, arrowheads). In Ptf1aCre;KrasG12D
mice, Sox9 was additionally detected in a subset of cells with
acinar morphology, expressing the acinar marker Cpa1, but
not the ductal marker CK19 (Figures 4B and 4D, arrows). These(E–K) Tamoxifen (TM) was administered to Ptf1aCreER;Sox9f/f;R26RYFP, Ptf1aCreER
mice at postnatal day (p) 21, 23, and 25 to simultaneously ablate Sox9 and induce
H&E and Alcian blue staining (I–K) shows almost no PanINs after Sox9 deletion.
(L–Q) Immunohistochemistry reveals expression of YFP in PanINs in both Ptf1a
mice (M,N). Sox9 expression in PanINs in the Sox9f/f background indicates lack
(R–AC) H&E (R–T) and Alcian blue staining (U–W) reveals abundant ADM and PanIN
mice at 3–4 weeks of age. Immunohistochemistry for HA (X–Z) and Sox9 (AA–
transgene.
(AD and AE) Quantification of Alcian blue+ pancreatic area reveals a significant re
Sox9 misexpression (n = 5).
(AF) Immunofluorescence staining shows abundant CK19 and little Cpa1 exp
CK19+Cpa1+ cell.
Values are shownasmean±SEM. *p<0.05 and ***p<0.001. Scale bars: 25mm(Aa
See also Figure S3.
Candata indicate that Sox9 expression is initiated before Kras-active
acinar cells progress to a duct-like state and become PanINs.
Since Sox9 is important for ductal cell development and regu-
lates critical ductal genes (Shih et al., 2012), we examined
whether Sox9 plays a role in the transformation of acinar cells
into ductal structures and premalignant lesions. To test if Sox9
is required for PanIN formation, we concomitantly induced
KrasG12D expression and deleted Sox9 in acinar cells in 3-
week-old Ptf1aCreER;KrasG12D;Sox9f/f;R26RYFP mice (Figures 4E
and S3A). Consistent with the lack of Sox9 expression in normal
acinar cells, acinar cell-specific Sox9 deletion did not affect
gross acinar cell morphology or the pattern of pancreatic Sox9
expression (Figures 4F, 4I, 4L, and 4O). Next, we analyzed
8- to 12-month-old Ptf1aCreER;KrasG12D;Sox9+/+;R26RYFP and
Ptf1aCreER;KrasG12D;Sox9f/f;R26RYFP mice for the presence of
PanINs. Confirming our previous findings (Figures 2E and 2F),
pancreata from Ptf1aCreER;KrasG12D;Sox9+/+;R26RYFP mice con-
tained widespread Alcian blue+ PanIN lesions, expressing the
YFP lineage label and Sox9 (Figures 4G, 4J, 4M, and 4P). In
striking contrast, pancreas morphology was virtually normal in
Sox9-deleted mice and very few PanINs were observed (Figures
4F, 4H, 4I, and 4K). Quantification of Alcian blue staining re-
vealed a 153-fold reduction in the Alcian blue+ area in Sox9-
deleted Ptf1aCreER;KrasG12D mice compared to mice with two
functional Sox9 alleles (Figure 4AD). Notably, PanINs that still
formed in Ptf1aCreER;KrasG12D;Sox9f/f;R26RYFP mice were YFP+
and Sox9+ (Figures 4N and 4Q), indicating that these PanINs
arose from acinar cells that recombined the R26RYFP and
KrasG12D alleles, but not the Sox9flox allele. Together, these find-
ings demonstrate that PanIN formation from Kras-active acinar
cells requires Sox9 activity (Figure S3R).
Sox9 Promotes KrasG12D-Mediated Induction of PanINs
Given the critical role of Sox9 in PanIN formation and its early
induction in Kras-active acinar cells, we next examined whether
forced expression of Sox9 potentiatesKrasG12D-mediated PanIN
formation. To test this idea, we crossed the well-characterized
Ptf1aCre;KrasG12D model of PanIN formation (Hingorani et al.,
2003) with mice harboring a Cre-inducible Sox9 transgene
(CAG-Sox9, hereafter referred to as Sox9OE). In Sox9OE mice,
RFP is ubiquitously expressed in all cells unless Cre-mediated
excision removes the RFP sequence and induces heritable
expression of a bicistronic transcript encoding GFP and HA-
tagged Sox9 (Figure S3B). Consistent with the propensity of
Ptf1aCre to mostly target acinar cells (Heiser et al., 2008),;LSL-KrasG12D;Sox9+/+;R26RYFP and Ptf1aCreER;LSL-KrasG12D;Sox9f/f;R26RYFP
KrasG12D in acinar cells. Mice were analyzed at 8–12 months (mo) of age. (F–H)
CreER;KrasG12D;Sox9+/+;R26RYFP and Ptf1aCreER;LSL-KrasG12D;Sox9f/f;R26RYFP
of Sox9f recombination (Q).
s in Ptf1aCre;LSL-KrasG12D;Sox9OE, but not in Ptf1aCre;LSL-KrasG12D or control
AC) shows Sox9+ PanINs originating from cells that recombined the Sox9OE
duction of PanINs after Sox9 deletion (n = 9) and conversely, an increase after
ression in 4-week-old Ptf1aCre;LSL-KrasG12D;Sox9OE mice. Arrow points to
ndB), 50mm(CandD), 100mm(L–Q,X–AC, andAF), and500mm(F–KandR–W).
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Figure 5. Sox9 Misexpression Induces
Ductal Genes
(A–F) Co-immunofluorescence staining for Cpa1
and CK19 shows CK19+Cpa+ cells in Ptf1aCre;
Sox9OEmice (B, D, and F), but not in controls (A, C,
and E).
(G and H) Immunohistochemistry for CK19
reveals greater staining intensity in 6-month-old
Ptf1aCre;Sox9OE than in control mice.
(I) QRT-PCR analysis ofMist1, amylase, and CK19
in whole pancreas RNA from Ptf1aCre;Sox9OE and
control mice (n = 5).
(J and K) H&E staining shows acinar clusters
with dilated lumens in 6-month-old Ptf1aCre;
Sox9OE mice (K, arrows). Values are shown as
mean ± SEM. *p < 0.05 and **p < 0.01. Scale
bars: 50 mm.
Cancer Cell
Sox9-Dependent Initiation of Pancreatic CancerPtf1aCre;Sox9OE mice expressed the HA-tag and Sox9
predominantly in acinar cells, whereas ducts and endocrine
clusters remained largely unrecombined and retained RFP
(Figures S3E–S3G and S3J–S3L). In 3-week-old Ptf1aCre;Sox9OE
mice, pancreatic weight, overall tissue morphology and blood
glucose levels were similar to control mice (Figures S3C, S3D,
S3H, S3I, S3M, and S3N), suggesting that Ptf1aCre-mediated
Sox9 misexpression has no overt effect on pancreatic
development.
Similar to Ptf1aCre;Sox9OE mice, Ptf1aCre;KrasG12D;Sox9OE
mice also developed normally until 3 weeks of age (data not
shown), but thereafter began to exhibit signs of exocrine insuffi-
ciency and changes in gross pancreatic morphology not seen in
Ptf1aCre;KrasG12D or Ptf1aCre;Sox9OE mice (Figures S3O–S3Q;
data not shown). Synergy between Sox9 and KrasG12D was
also observed at a microscopic level, as evidenced by
replacement of normal pancreas parenchyma by large areas of
Sox9+ ADM and Alcian blue+ PanINs in Ptf1aCre;KrasG12D;
Sox9OE mice (Figures 4T, 4W, and 4AC); a phenotype not seen
in age-matched Ptf1aCre;KrasG12D or control mice (Figures 4R,
4S, 4U, 4V, 4X, 4Y, 4AA, and 4AB). The pancreatic area occupied
specifically by Alcian blue+ PanIN lesions was 17-fold greater
in Ptf1aCre;KrasG12D;Sox9OE than in Ptf1aCre;KrasG12D mice
(Figure 4AE). Detection of the HA-tag in both ADM and PanIN
lesions further demonstrated that they arose from cells
expressing the Sox9OE transgene (Figure 4Z). Because Ptf1aCre
predominantly targets acinar cells (Figures S3K and S3L), these
findings suggest that concomitant misexpression of Sox9 and
KrasG12D rapidly induces transformation of acinar cells into
duct-like cells and subsequent PanIN formation. Consistent
with this notion, very few cells retained Cpa1 in Ptf1aCre;
KrasG12D;Sox9OE mice and CK19+ ductal structures were
predominant (Figure 4AF). Within these structures, few CK19+744 Cancer Cell 22, 737–750, December 11, 2012 ª2012 Elsevier Inc.cells coexpressed Cpa1 (Figure 4AF,
arrows), indicating that most cells had
already transitioned from a CK19+Cpa1+
into a CK19+Cpa1 state characteristic
of ADR (De La O et al., 2008; Morris
et al., 2010). Together, these results
suggest that Sox9 accelerates KrasG12D-
mediated PanIN formation by suppress-ing a mature acinar cell program and/or promoting a duct-like
state (Figure S3R).
Sox9 Induces Ductal Genes in Acinar Cells
To determine whether forced expression of Sox9 in acinar cells
induces a duct-like state in the absence of oncogenic Kras, we
examined Ptf1aCre;Sox9OE mice for coexpression of CK19 with
Cpa1. In Ptf1aCre;Sox9OE mice at 3 weeks of age or older,
Cpa1 colocalized with CK19, whereas the two domains re-
mained separate in control mice (Figures 5A–5F). QRT-PCR
confirmed the increase in CK19 and also revealed a decrease
in acinar cell-specific genes (Figure 5I). While these molecular
changes are indicative of acinar cell de-differentiation, the
CK19+Cpa1+ cells largely retained acinar morphology and did
not form duct-like structures (Figures 5E–5H, 5J, and 5K). This
suggests that Sox9 expression in acinar cells destabilizes the
acinar cell state and promotes expression of ductal genes, but
is not sufficient to induce complete ductal reprogramming.
Sox9 Promotes Acinar-to-Ductal Reprogramming and
Induces Mucinous Metaplasia after Pancreatic Injury
Although Kras activation induces ADM and PanINs, it does so
with considerable latency, which is significantly shortened in
the presence of pancreatitis (De La O and Murtaugh, 2009;
Guerra et al., 2007; Morris et al., 2010). To test whether Sox9,
like oncogenic Kras, requires inflammatory cues to initiate wide-
spread ADM, we induced acute pancreatitis in Ptf1aCre;Sox9OE
mice. Injection with caerulein on consecutive days (Figure 6A) re-
sulted in loss of acinar morphology and induction of Sox9 and
CK19 in a subset of Cpa1+ cells 2 days after treatment (Figures
6C, 6I, and 6O). In control mice, normal pancreatic morphology
was restored after 7 days and CK19 and Sox9 expression was
again restricted to ductal cells (Figures 6B, 6D, 6H, 6J, 6N, and
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Figure 6. Sox9 Promotes Persistent ADR and Formation of
Mucinous Metaplastic Lesions after Acute Pancreatitis
(A) Six-week-old Ptf1aCre;Sox9OE and control mice were treated with two sets
of caerulein (CA) or saline injections on consecutive days and analyzed 48 hr (h)
or 7 days (d) later. Saline-treated mice were analyzed at 21 days.
(B–G) H&E staining reveals persistent ADM in Ptf1aCre;Sox9OE mice (G).
(H–M) Co-immunofluorescence staining for CK19 and Cpa1 shows a few
CK19+Cpa1+ (L, arrow) 48 hr after CA and mainly CK19+Cpa1 cells after
7 days (M) in Ptf1aCre;Sox9OE mice.
(N–S) Immunohistochemistry for Sox9 and Alcian blue staining shows
Sox9+Alcian blue+ mucinous metaplastic lesions in Ptf1aCre;Sox9OE mice (S)
but not in control mice (P) 7 days after CA.
(T) Schematic summarizing the phenotypes of Sox9misexpressing mice in the
presence and absence ofKrasG12D or acute pancreatitis. w, weeks. Scale bars:
100 mm (B–G) and 50 mm (H–S).
See also Figure S4.
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Can6P). Two days after caerulein administration, Ptf1aCre;Sox9OE
mice displayed more severe ductal metaplasia than control
mice (Figures 6C and 6F) with numerous CK19+Cpa1 and
Sox9+ cell clusters (Figures 6L and 6R). After 7 days, acinar
morphologywasnot restoredandCK19+Cpa1ductal structures
characteristic of ADRpersisted (Figures 6E–6G, 6K–6M, and 6Q–
6S). These findings show that Sox9misexpression is sufficient to
promote reprogramming of acinar cells into a persistent duct-like
state after pancreatic injury. Interestingly, a subset of the persis-
tent ductal structures that arose fromcells expressing theSox9OE
transgene were Sox9+Alcian blue+ (Figures S4A–S4G and 6S).
These lesions displayed morphologic similarity to mucinous
lesions observed in a chronic pancreatitis model (Strobel et al.,
2007) with little cellular atypia and low amounts of acidic mucins
compared to KrasG12D-induced PanINs. Since acute pancreatitis
alone is not sufficient to induce mucinous duct-like lesions, our
data suggest that persistent expression of Sox9 in acinar cells
in the context of tissue injury can initiate a cell state with some
characteristics of mucinous PDA precursor lesions (Figure 6T).
Sox9 Is Not Absolutely Required for Injury-Induced
Acinar-to-Ductal Metaplasia but Is Necessary for
Further Progression into PanINs
Deletion of Sox9 in the presence of oncogenic Kras completely
blocked KrasG12D-mediated changes in pancreas morphology,
including the development of ADM and PanINs (Figures 4E–
4Q). However, it remains unclear whether pancreatic injury can
still induce ADM and premalignant lesions in the absence of
Sox9. To address this question, we deleted Sox9 in acinar cells
and examined pancreata for ADM after caerulein treatment (Fig-
ure S4H). As expected, control mice exhibited transient ADM
characterized by ectopic Sox9 and CK19 expression in acinar
cells 2 days after caerulein treatment (Figures S4J, S4P, and
S4V, arrows). Similar lesions devoid of Sox9 were found in caer-
ulein-treated Ptf1aCreER;Sox9f/f mice (Figures 4M, 4S, and 4Y,
arrows), suggesting that Sox9 activity is not absolutely required
to initiate ADM. In both control and Sox9-deleted mice, areas of
ADMwere replaced by normal acinar tissue after 7 days (Figures
S4I, S4K, S4L, S4N, S4O, S4Q, S4R, S4T, S4U, S4W, S4X, and
S4Z). These data suggest that pancreatic injury can induce
ADM-initiating cues independent of Sox9.
The finding that pancreatitis causes ADM even in the absence
of Sox9 raises the question of whether Sox9-deleted acinar cells
can undergo ADR and form PanINs if expression of oncogeniccer Cell 22, 737–750, December 11, 2012 ª2012 Elsevier Inc. 745
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Sox9-Dependent Initiation of Pancreatic CancerKras is combined with pancreatic injury. To first examine
whether Sox9 is necessary for KrasG12D-mediated ADR, we
deleted Sox9 and activated KrasG12D expression in Ptf1aCreER;
KrasG12D;Sox9f/f mice at 3 weeks of age and induced acute
pancreatitis 3 weeks later (Figures 7A and S5A). Because Kras
had only been active for 6 weeks, PanINs were still rare in
Ptf1aCreER;KrasG12D;Sox9+/+ mice in the absence of caerulein
(Figure 7G). Caerulein induced widespread formation of Sox9+
ADM in Ptf1aCreER;Sox9+/+ and Ptf1aCreER;KrasG12D;Sox9+/+
mice within 2 days after treatment (Figures 7B, 7C, 7G, 7H,
S5B, S5C, S5E, and S5F). Notably, in Sox9-deleted Ptf1aCreER;
KrasG12D;Sox9f/f pancreata, Sox9 duct-like structures were still
present (Figures 7L, 7M, S5H, and S5I, arrows), confirming our
previous observation that Sox9 is not absolutely required for
injury-induced ADM. As expected, ADM was transient in the
absence of KrasG12D and the ductal structures were replaced
by Cpa1+ acini after 21 days (Figures 7B, 7D, 7E, S5B, and
S5D). In contrast, Kras-active Ptf1aCreER;KrasG12D;Sox9+/+
mice displayed persistent Sox9+ ADM (Figures 7I and S5G,
arrows), CK19+Cpa1 duct-like structures (Figure 7J, arrow),
as well as numerous Sox9+ lesions with morphologic character-
istics of PanINs (Figures 7J, 7K, and S5G, arrowheads). Signifi-
cantly, Sox9 deletion in the presence of oncogenic Kras
abrogated caerulein-induced PanIN formation, while some
Sox9CK19+Cpa1 duct-like lesions persisted (Figures 7N,
7O, and S5J, arrows). Consistent with these findings, numerous
Alcian blue+ cells were detected in Ptf1aCreER;KrasG12D;Sox9+/+
mice, but virtually none in Ptf1aCreER;KrasG12D;Sox9f/f mice
(Figures 7F, 7K, 7P, and 7Q). Remaining Alcian blue+ lesions in
Ptf1aCreER;KrasG12D;Sox9f/f mice were Sox9+ (Figures S5K–
S5M) and therefore escaped recombination. Together, these
findings show that pancreatic injury can, at least partially, over-
come the block in ADM caused by Sox9 inactivation in Kras-
active acinar cells, but cannot induce PanINs in the absence of
Sox9 (Figure 7R). Thus, Sox9 is critically required for reprogram-
ming of acini into PanINs.
DISCUSSION
The Cellular Origin of PanINs
Our study demonstrates that acinar cells exhibit a much higher
propensity to form PanINs after oncogenic mutation of Kras
than ductal or CACs. This finding was surprising, because
PDA has been suggested to originate from CACs due to shared
molecular features between PanINs and CACs. Notably,
although exceedingly low in frequency, PanINs were observed
after Sox9CreER-mediated KrasG12D activation. Since the
Sox9CreER transgene also induces recombination in a small
number of acinar cells, one possibility is that these rare PanINs
originated from acinar cells that recombined the KrasG12D
allele. However, we observed that the PanINs were predomi-
nantly associated with large pancreatic ducts, which argues
against an acinar origin. A similar association of PanINs with
large ducts has been described in CK19CreER;KrasG12D mice,
a model in which recombination is mainly induced in large ducts
and not in small ducts or CACs (Ray et al., 2011). Together,
these observations suggest that large pancreatic ducts, but
not CACs, can give rise to PanINs, albeit at an extremely low
frequency.746 Cancer Cell 22, 737–750, December 11, 2012 ª2012 Elsevier IncThe location of PanINs close to large ducts points to a possible
involvement of pancreatic duct glands in PanIN formation.
Pancreatic duct glands are small blind-ended pouches within
the larger pancreatic ducts that express embryonic progenitor
markers, proliferate in response to pancreatitis, and display
somemetaplastic features similar to PanINs even in the absence
of oncogenicmutations (Strobel et al., 2010). These featuresmay
render pancreatic duct glands susceptible to transformation by
oncogenic Kras. The scarcity of pancreatic duct glands within
the organ could explain why despite targeting of duct glands
by the Sox9CreER transgene (Kopp et al., 2011), PanIN
frequency was extremely low in Sox9CreER;KrasG12D mice. Of
note, because recombination was only induced in 12% of all
Sox9+ cells by our tamoxifen regimen, the duct glands may not
have been targeted in every mouse, which is consistent with
the absence of PanINs in a subset of Sox9CreER;KrasG12D
mice. At present, very little is known about the biological role
of pancreatic duct glands, but their possible involvement in
PDA initiation warrants further investigation.
Our finding that ductal and CACs do not readily form PanINs
in response to oncogenic Kras raises the question of whether
the ductal/CAC compartment is generally refractory to onco-
genic transformation. In addition to activating mutations in
KRAS, loss-of-function mutations in the tumor suppressors
TP53, CDKN2A, or PTEN have also been found in PDA (Feld-
mann et al., 2007; Kanda et al., 2012; Ying et al., 2011). Notably,
Pten loss results in rapid formation of invasive carcinoma, which
is preceded by significant expansion of CACs (Stanger et al.,
2005). This suggests that CACs, ductal cells and acinar cells
may have the potential to initiate invasive carcinoma, but
that each cellular context may require a different repertoire of
genetic alterations for tumor initiation. Cell-specific induction of
different oncogenic mutations in mice may define morphologi-
cally and molecularly distinct tumors, which may help identify
human PDA subtypes that respond differently to therapeutic
intervention.
Duct-Associated Genes Orchestrate the Emergence
of Premalignant Lesions from Acinar Cells
Our cell tracing studies show that the predominant mechanism
by which KrasG12D induces PanINs is to initiate a gene expres-
sion program similar to pancreatic ducts in acinar cells. We
further show that the transcription factor Sox9 promotes, and
is required for, PanIN formation from the acinar cell compart-
ment. Recent studies have revealed a role for Sox9 in maintain-
ing ductal cell morphology and regulating duct-specific genes
(Delous et al., 2012; Manfroid et al., 2012; Shih et al., 2012), sug-
gesting that Sox9 might have a similar function during acinar cell
conversion into PanINs. Consistent with this notion, we found
that Sox9 induces CK19 expression and promotes ADR in the
presence of KrasG12D or pancreatic injury. Furthermore, a role
for Sox9 in conferring certain ductal characteristics to cells has
recently been demonstrated in a model of surgically-induced
pancreatitis (Prevot et al., 2012). While Sox9 promotes ADM
and ADR in gain-of-function experiments, our results show that
tissue injury can still, to some extent, induce ADM from Sox9-
deficient acinar cells. This suggests that other factors can
compensate for Sox9 during injury-induced ADM. One candi-
date is the duct-specific transcription factor Hnf6, which is.
Saline 48h 21d
Time after Caerulein Treatment
G H I
L NM
P
tf1
aC
re
E
R
;S
ox
9+
/+
P
tf1
aC
re
E
R
;S
ox
9+
/+
P
tf1
aC
re
E
R
;S
ox
9f
/f
LS
L-
K
ra
sG
12
D
Alcian Blue/Eosin
0 
1 
2 
3 
4 
5 
6 
A
lc
ia
n 
B
lu
e 
To
ta
l P
an
cr
ea
tic
  A
re
a 
(%
)
Sox9+/+ Sox9f/fSox9+/+
LSL-KrasG12D
Ptf1aCreER
J
O
Q *
p21-25 9w
TM
Analysis
Analysis
6w
48h
CA
48h
CA
21d
B C D E F
K
P
Sox9/CK19/Cpa1
A
R
PanINADRADMNormal
K
ra
sG
12
D
So
x9
+/
+
+I
nj
ur
y
K
ra
sG
12
D
So
x9
f/f
+I
nj
ur
y
No
Progression
Figure 7. Sox9-Deficient Acinar Cells Expressing KrasG12D Can Undergo Persistent ADR after Acute Pancreatitis, but Do Not Progress into
PanINs
(A) Ptf1aCreER;Sox9+/+, Ptf1aCreER;LSL-KrasG12D;Sox9+/+ and Ptf1aCreER;LSL-KrasG12D;Sox9f/fmice were injected with tamoxifen (TM) at postnatal day (p) 21, 23,
and 25. At 6 weeks (w) of age, mice were treated with two sets of caerulein (CA) or saline injections on alternating days and analyzed 48 hr (h) or 21 days (d) later.
(B–D, G–I, and L–N) H&E staining shows persistent ADM in Ptf1aCreER;LSL-KrasG12D;Sox9+/+ and to a lesser extent also in Ptf1aCreER;LSL-KrasG12D;Sox9f/f mice
(I and N, arrows). PanINs are only present in Ptf1aCreER;LSL-KrasG12D;Sox9+/+ mice (I), arrowhead).
(E, J, and O) Co-immunofluorescence staining for CK19, Cpa1, and Sox9 reveals CK19+Cpa1 duct-like cell clusters in Ptf1aCreER;LSL-KrasG12D mice in the
presence and absence of Sox9 (J and O, arrows).
(F, K, and P) Alcian blue and eosin staining shows PanINs inPtf1aCreER;LSL-KrasG12D;Sox9+/+mice (K), but not inPtf1aCreER;LSL-KrasG12D;Sox9f/fmice (P). Arrows
in K and P point to ADM and arrowheads in J and K to PanINs.
(Q) Quantification of Alcian blue+ pancreatic area 21 days after CA (n = 4–5).
(R) Schematic summarizing the phenotype observed in Sox9 loss-of-function experiments in the presence of KrasG12D and acute pancreatitis. Values are shown
as mean ± SEM. *p < 0.05. Scale bars: 50 mm.
See also Figure S5.
Cancer Cell
Sox9-Dependent Initiation of Pancreatic Cancer
Cancer Cell 22, 737–750, December 11, 2012 ª2012 Elsevier Inc. 747
Cancer Cell
Sox9-Dependent Initiation of Pancreatic Cancerinduced in acinar cells by pancreatic injury and is both necessary
and sufficient for ADM (Prevot et al., 2012). In the absence of
Sox9, however, Hnf6 is less efficient in inducing CK19 (Prevot
et al., 2012), suggesting synergy between Hnf6 and Sox9 during
ductal conversion of acinar cells. Different from Sox9, Hnf6
expression is not maintained in PanINs and PDA (Prevot et al.,
2012). Therefore, only Sox9 expression is sustained in PanINs,
providing a possible explanation for why Sox9 is absolutely
required for PanIN formation.
Acinar-derived duct-like lesions and pancreatic ducts display
similarmolecular andmorphological features, yetPanINsemerge
more readily from acinar-derived duct-like cells than ductal
cells. This implies that duct-like lesions differ from native pancre-
atic ducts. The transcription factors Sox9, Hnf6, and Hes1 are
not only markers for pancreatic ductal cells, but are also ex-
pressed in multipotent progenitors of the developing pancreas
(Jacquemin et al., 2003; Miyamoto et al., 2003; Seymour et al.,
2007), raising the question of whether ADM is truly ductal
in nature or more closely resembles embryonic progenitors.
Previous studies have suggested that ADM lesions are similar
to immature embryonic progenitor-like cells because they ex-
press Pdx1, Nestin, and Hes1 (Jensen et al., 2005; Miyamoto
et al., 2003; Shi et al., 2012; Song et al., 1999). However, multipo-
tent progenitor markers, such as Hnf1b and Nkx6.1 (Schaffer
et al., 2010; Solar et al., 2009), are not present in acinar-derived
duct-like cells (Jensen et al., 2005; Prevot et al., 2012) indicating
that these cells may resemble an acinar-committed yet still
immature Nestin-positive progenitor cell (Carrie`re et al., 2007;
Esni et al., 2004). Comparative transcriptome analysis of these
different native and transformed cell populations will shed light
on the molecular differences between these populations and
could provide clues as to why PanINs readily emerge from acinar
cells, but not ducts, in response to oncogenic Kras.
The Role of Acinar-to-Ductal Metaplasia in the Initiation
of Pancreatic Neoplasia
Our finding that PanINs predominantly originate from acinar cells
identifies the transition of acinar cells into a duct-like state as an
important early event in tumor initiation. In addition to induction
of ductal genes, destabilization of the acinar cell phenotype
appears to also promote ADM and PanINs, as evidenced by an
acceleration in KrasG12D-mediated ADM and PanIN formation
after deletion of the acinar-restricted transcription factor Mist1
(Shi et al., 2009, 2012). This suggests that the observed synergy
between oncogenic Kras and Sox9misexpression or pancreatic
injury in PanIN initiation might be a result of each condition
increasing acinar cell plasticity. Therefore, known risk factors
for PDA, such as chronic pancreatitis or genetic variants of
acinar-specific genes (Li et al., 2012; Lowenfels et al., 1993,
1997), may increase PDA risk by rendering acinar cells more
plastic and reducing the threshold for ADM. It is important to
note that a direct lineage relationship between ADM and PanINs
has yet to be formally demonstrated and the possibility remains
that ADM lesions do not directly transition into PanINs. However,
it is clear that both ADM and PanIN lesions arise from acinar cells
(Guerra et al., 2007; Morris et al., 2010) and that reducing ADM
formation through inhibition of the EGFR pathway or overexpres-
sion of pro-acinar genes reduces KrasG12D-induced PanINs
(Ardito et al., 2012; Navas et al., 2012; Shi et al., 2012). This748 Cancer Cell 22, 737–750, December 11, 2012 ª2012 Elsevier Incsuggests that pathways critical for ADM are also necessary for
PanIN formation.
Our results imply that therapeutic targeting of signaling path-
ways involved in ductal reprogramming of acinar cells could
prevent PDA initiation. Previous studies have demonstrated
that the EGFR, Hedgehog and Notch signaling pathways
promote ADM and PanIN formation (De La O et al., 2008; Fen-
drich et al., 2008; Miyamoto et al., 2003; Pasca di Magliano
et al., 2006; Rajurkar et al., 2012; Siveke et al., 2007). Interest-
ingly, these pathways are known to be upstream regulators of
Sox9 expression in multiple organs (Bien-Willner et al., 2007;
Haller et al., 2012; Ling et al., 2010; Meier-Stiegen et al., 2010;
Muto et al., 2009; Zong et al., 2009). Moreover, Notch signaling
has recently been shown to control Sox9 expression and induce
ductal genes in the pancreas (Delous et al., 2012; Manfroid
et al., 2012; Shih et al., 2012). Therefore, it is possible that
Sox9 is the critical effector of Notch during PanIN induction.
Consistent with this notion, inhibition of Notch signaling in the
presence of oncogenic Kras reduced PanIN formation (Plentz
et al., 2009), similar to Sox9 inactivation in our current study.
However, it remains to be examined how inputs from different
signaling pathways converge on Sox9 to promote PanIN initia-
tion. Our findings now pave the way for future studies exploring
whether the inhibition of acinar cell plasticity could have thera-
peutic applications in the prophylaxis of PDA in high-risk
individuals.
EXPERIMENTAL PROCEDURES
Mouse Procedures
All animal experiments described herein were approved by the University
of California, San Diego and San Francisco Institutional Animal Care and Use
Committees. The sources for mouse strains as well as genotyping and glucose
measurement strategies are described in the Supplemental Experimental
Procedures. Tamoxifen (Sigma-Aldrich) was dissolved in corn oil and adminis-
tered subcutaneously at 5 mg/40 g per injection. Mice were injected with caer-
ulein (50mg/kgdiluted in saline; Sigma-Aldrich) or saline on twoalternating days
once every hour for 6 hours each day (used in experiments withKrasG12Dmice)
or on two consecutive days once every hour for 8 hours each day (used in
experiments in absence of KrasG12D allele) (Morris et al., 2010).
Histology, Immunohistochemical and Immunofluorescence Analysis
Paraffin-embedded or frozen sections were subjected to hematoxylin (Mayers
or Harris formulations), eosin, Alcian blue, nuclear fast red (Vector Labs),
immunohistochemical or immunofluorescence staining as described (Morris
et al., 2010; Seymour et al., 2007, 2008). Detailed procedures for histologic
and morphometric analyses, as well as a list of primary and secondary
antibodies can be found in the Supplemental Experimental Procedures.
Statistical Analysis
P values were calculated using the two-tailed Student’s t test with the Graph-
Pad Prism or Excel software.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures, one table, and Supplemental
Experimental Procedures and can be found with this article online at http://
dx.doi.org/10.1016/j.ccr.2012.10.025.
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